§ Same category · GLP-1 / metabolic peptides
Orforglipron vs Survodutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
Orforglipron
0
vendors tracked
Survodutide
3
vendors tracked
from $6.50/mg
Orforglipron
Oral small-molecule GLP-1 agonist
No current listings at 0.024mg.
Survodutide
Glucagon/GLP-1 dual agonist
Operational
$64.99
$6.50/mg
In stock◎ Best $/mg
B
Operational$78.00
$7.80/mg
In stock▲ 20.0% vs best
B-
Watch$95.00
$9.50/mg
In stock▲ 46.2% vs best
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Glacier Aminos US | B | Operational | $64.99 ◎ Best $/mg | $6.50 | In stock | Buy with code → | |
| EZ Peptides US | B | Operational | $78.00 ▲ 20.0% | $7.80 | In stock | Visit → | |
| Ameano Peptides US | B- | Watch | $95.00 ▲ 46.2% | $9.50 | In stock | Visit → |
Sort:
Last crawl 2026-11-12Sort:
2026-11-12About Orforglipron
An oral non-peptide GLP-1 receptor agonist in Phase 3 for obesity and type-2 diabetes. Typically sold as capsules in research-compound form.
About Survodutide
A dual glucagon/GLP-1 receptor agonist in clinical trials for obesity and MASH. Research-compound version sold as the free acid.